XML 25 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Operating expenses:    
Research and development [1] $ 47,444 $ 32,330
General and administrative 21,440 10,079
Total operating expenses 68,884 42,409
Loss from operations (68,884) (42,409)
Other income (expense):    
Change in fair value of the related party antidilution obligation   (836)
Change in fair value of Series A preferred stock tranche obligation   (28)
Interest income, net 623 3
Other income (expense), net (44) (13)
Total other expense, net 579 (874)
Net loss and comprehensive loss $ (68,305) $ (43,283)
Net loss per share attributable to common stockholders, basic $ (2.16) $ (28.26)
Net loss per share attributable to common stockholders, diluted $ (2.16) $ (28.26)
Weighted-average common shares outstanding, basic 31,685,125 1,531,686
Weighted-average common shares outstanding, diluted 31,685,125 1,531,686
[1] Includes related party amounts of $295 for the year ended December 31, 2022, and $2,672 for the year ended December 31, 2021 (see Note 13).